SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ARIAD Pharmaceuticals
ARIA 23.990.0%Feb 17 4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dr. John M. de Castro who wrote (360)11/12/1998 10:27:00 AM
From: Mike McFarland  Read Replies (4) of 4474
 
Third Quarter and 5M placement

ARIAD Reports Third Quarter 1998 Financial Results
biz.yahoo.com

ARIAD Completes $5 Million Private Placement
biz.yahoo.com

Each share of Series C Convertible Preferred Stock has a stated value of $1,000, plus an accrual amount equal to 5% per annum, and is convertible into common stock of the Company beginning approximately three months after the initial closing, at a conversion price equal to the lower of a Variable Conversion Price or a Maximum Conversion Price geeze, what is all that gobbledegook

So, how many shares of the common do you get for exchanging a
share of the convertible? Guess it will be on edgar soon, these
things always seem kinda stinky for shareholders of the common,
but so far the stock is holding up.

John--I like your idea about extending the life of the warrants,
but I wonder how often such a thing really occurs. Not that I
wouldn't be happy to see them do some things for the little
guys
who were already in this. Oh well, I guess they needed
the money, that should buy them a couple more quarters yes,
with what they have on hand they should be in business at least
a year...will have to go over the financial again.

--MM
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext